Cargando…
Tofacitinib: Increased D-Dimer level: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417666/ http://dx.doi.org/10.1007/s40278-021-01906-1 |
Ejemplares similares
-
d-Dimer trend in a long-term rheumatoid arthritis patient with tofacitinib treatment and recent COVID-19 infection
por: Maldonado, Genessis, et al.
Publicado: (2022) -
Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022) -
Tofacitinib in recalcitrant scleritis: First case report from India
por: Pyare, Richa, et al.
Publicado: (2020) -
Mesalazine/tofacitinib/vedolizumab: COVID-19 infection: 3 case reports
Publicado: (2021) -
Methotrexate/tofacitinib/tozinameran interaction: COVID-19 pneumonia: case report
Publicado: (2022)